Drug intelligence / Profile preview

microRNA-200c

Development stage
Preclinical
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

microRNA-200c (miR-200c) is a member of the miR-200 family and acts as a master regulator of the epithelial phenotype. It functions primarily as a tumor suppressor by inhibiting the expression of transcription factors such as ZEB1 and ZEB2, which are critical drivers of epithelial-to-mesenchymal transition (EMT). In aggressive cancers like triple-negative breast cancer (TNBC), miR-200c is often downregulated, and its restoration has been shown to suppress tumor growth and metastasis. Beyond its direct effects on tumor cells, miR-200c modulates the tumor microenvironment by inducing a cytokine profile (including the upregulation of GM-CSF) that promotes the polarization of macrophages toward an antitumor M1 phenotype. While currently in the preclinical stage of development, miR-200c mimics represent a potential RNA-based therapeutic strategy for treating metastatic and immune-suppressive cancers.

Other names
miR-200c-3pmiR200c-3pmiR 200c-3pmicroRNA 200cmicroRNA200cmicroRNA-200c
02

Targets

ZEB1 (Zinc finger E-box-binding homeobox 1)ZEB2 (Zinc finger E-box-binding homeobox 2)

Beyond the preview

Go deeper on microRNA-200c.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-200c.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call